FDA Advisors Weigh COX-2 Inhibitor Safety

(MedPage Today) -- Celecoxib, day 1: little objection to label updates, but plenty of open questions

Source: MedPage Today Rheumatology - April 25, 2018 Category: Rheumatology Source Type: news